As of close of business last night, Twist Bioscience Corp’s stock clocked out at $34.80, down -5.59% from its previous closing price of $36.86. In other words, the price has decreased by -$2.06 from its previous closing price. On the day, 759198 shares were traded. TWST stock price reached its highest trading level at $37.28 during the session, while it also had its lowest trading level at $34.40.
Ratios:
To gain a deeper understanding of TWST’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.51 and its Current Ratio is at 5.98. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on January 17, 2024, Upgraded its rating to Buy and sets its target price to $45 from $25 previously.
On September 27, 2023, Berenberg started tracking the stock assigning a Buy rating and target price of $27.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $33.Scotiabank initiated its Sector Outperform rating on January 05, 2023, with a $33 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 06 ’24 when Leproust Emily M. sold 1,487 shares for $37.43 per share. The transaction valued at 55,658 led to the insider holds 516,409 shares of the business.
Green Paula sold 600 shares of TWST for $22,458 on Mar 06 ’24. The SVP of Human Resources now owns 92,850 shares after completing the transaction at $37.43 per share. On Mar 06 ’24, another insider, Banyai William, who serves as The insider of the company, sold 549 shares for $37.43 each. As a result, the insider received 20,549 and left with 346,755 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TWST now has a Market Capitalization of 2.01B and an Enterprise Value of 1.79B. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.67 while its Price-to-Book (P/B) ratio in mrq is 3.41. Its current Enterprise Value per Revenue stands at 6.83 whereas that against EBITDA is -10.40.
Stock Price History:
Over the past 52 weeks, TWST has reached a high of $43.21, while it has fallen to a 52-week low of $11.46. The 50-Day Moving Average of the stock is 36.49, while the 200-Day Moving Average is calculated to be 25.32.
Shares Statistics:
It appears that TWST traded 1.18M shares on average per day over the past three months and 771.65k shares per day over the past ten days. A total of 57.56M shares are outstanding, with a floating share count of 55.29M. Insiders hold about 4.37% of the company’s shares, while institutions hold 109.15% stake in the company. Shares short for TWST as of Feb 29, 2024 were 12.4M with a Short Ratio of 10.48, compared to 12.33M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 21.44% and a Short% of Float of 28.11%.
Earnings Estimates
As of right now, 9 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.81 for the current quarter, with a high estimate of -$0.75 and a low estimate of -$0.86, while EPS last year was -$1.04. The consensus estimate for the next quarter is -$0.77, with high estimates of -$0.69 and low estimates of -$0.84.
Analysts are recommending an EPS of between -$2.84 and -$3.24 for the fiscal current year, implying an average EPS of -$3.08. EPS for the following year is -$2.7, with 9 analysts recommending between -$1.97 and -$3.29.
Revenue Estimates
A total of 9 analysts have provided revenue estimates for TWST’s current fiscal year. The highest revenue estimate was $299.96M, while the lowest revenue estimate was $290.5M, resulting in an average revenue estimate of $293.24M. In the same quarter a year ago, actual revenue was $245.11M, up 19.60% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $354.11M in the next fiscal year. The high estimate is $384.87M and the low estimate is $340.4M. The average revenue growth estimate for next year is up 20.80% from the average revenue estimate for this year.
